We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-14.57%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.18B
AUM Growth
-$215M
Cap. Flow
+$233M
Cap. Flow %
10.67%
Top 10 Hldgs %
53.45%
Holding
100
New
9
Increased
46
Reduced
19
Closed
23

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$61.3M
2
BIIB icon
Biogen
BIIB
+$45.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$37.2M
4
MRK icon
Merck
MRK
+$26.9M
5
STJ
St Jude Medical
STJ
+$25.3M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$26.6M
2
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
+$25.4M
3
OMED
OncoMed Pharmaceuticals, Inc.
OMED
+$25.3M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$21.7M
5
HALO icon
Halozyme
HALO
+$16.2M

Sector Composition

Rank Sector Weight
1 Healthcare 94.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STJ
26
DELISTED
St Jude Medical
STJ
$22.4M 1.03%
354,911
+354,606
+116,264% +$25.3M
UNH icon
27
UnitedHealth
UNH
$379B
$22.2M 1.02%
+191,148
New +$22.9M
EW icon
28
Edwards Lifesciences
EW
$47.8B
$21.8M 1%
918,690
-16,260
-2% -$392K
AIMT
29
DELISTED
Aimmune Therapeutics
AIMT
$20.1M 0.92%
+792,638
New +$18.5M
PTCT icon
30
PTC Therapeutics
PTCT
$6.29B
$18.4M 0.84%
690,364
+75,622
+12% +$3.23M
CMRX
31
DELISTED
Chimerix, Inc.
CMRX
$18.2M 0.83%
476,500
+1,600
+0.3% +$79K
SRRA
32
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$17.3M 0.79%
+21,569
New +$24.3M
VTRS icon
33
Viatris
VTRS
$20.5B
$16.8M 0.77%
417,082
+40,131
+11% +$2.24M
RDY icon
34
Dr. Reddy's Laboratories
RDY
$9.8B
$16.3M 0.75%
1,274,505
+35,935
+3% +$446K
RLYP
35
DELISTED
RELYPSA INC COM
RLYP
$15.6M 0.71%
842,030
– –
QURE icon
36
uniQure
QURE
$2.63B
$15.6M 0.71%
761,913
+112,113
+17% +$2.95M
XLRN
37
DELISTED
Acceleron Pharma
XLRN
$15.2M 0.7%
612,184
-39,900
-6% -$1.2M
TGTX icon
38
TG Therapeutics
TGTX
$8.53B
$14.8M 0.68%
1,464,105
+692,088
+90% +$10.3M
TVRD
39
Tvardi Therapeutics
TVRD
$23.8M
$14.6M 0.67%
+28,425
New +$19M
NVS icon
40
Novartis
NVS
$297B
$13.4M 0.61%
162,160
-25,892
-14% -$2.3M
ADXS
41
DELISTED
Advaxis Inc
ADXS
$12.9M 0.59%
+84,228
New +$20.4M
NVO
42
Novo Nordisk
NVO
$220B
$12.8M 0.58%
470,750
+35,800
+8% +$1.01M
HTWR
43
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$11.7M 0.54%
224,580
+46,006
+26% +$3.49M
NXTM
44
DELISTED
NxStage Medical Inc.
NXTM
$11.2M 0.51%
712,329
-459,867
-39% -$7.37M
ISRG icon
45
Intuitive Surgical
ISRG
$128B
$11.1M 0.51%
216,864
-108,828
-33% -$6.16M
RGNX icon
46
Regenxbio
RGNX
$622M
$10.8M 0.5%
+507,441
New +$13M
IMDZ
47
DELISTED
Immune Design Corp.
IMDZ
$10.3M 0.47%
845,867
+35,477
+4% +$665K
TDOC icon
48
Teladoc Health
TDOC
$1.61B
$9.31M 0.43%
+417,700
New +$11.3M
SGNT
49
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$8.98M 0.41%
585,659
+120,034
+26% +$2.59M
ACHC icon
50
Acadia Healthcare
ACHC
$2.99B
$8.49M 0.39%
+128,054
New +$9.85M
1
2
3 4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Sectoral Asset Management held 100 positions worth $2.18B, down 9% from $2.4B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Sectoral Asset Management deployed $233M of net new capital in Q3 2015, opening 9 new positions and adding to 46 existing holdings. Its largest new stake was Sierra Oncology, Inc. Common Stock: 21,569 shares worth $17.3M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 91% a quarter earlier.

On the sell side, the largest reduction was ZS PHARMA INC COMS TK (DE), an estimated $25.4M trimmed.

  • Sectoral Asset Management's largest Q3 2015 buy was Sierra Oncology, Inc. Common Stock: 21,569 shares worth $17.3M.
  • Sectoral Asset Management added most to Gilead Sciences in Q3 2015, an estimated $61.3M increase.
  • Sectoral Asset Management's biggest Q3 2015 reduction was ZS PHARMA INC COMS TK (DE), cutting an estimated $25.4M.
  • Sectoral Asset Management fully exited Abbott in Q3 2015, selling an estimated $26.6M.
  • Sectoral Asset Management's ten largest holdings make up 53% of its $2.18B portfolio in Q3 2015.
  • Sectoral Asset Management opened 9 new positions and closed 23 in Q3 2015.
  • Sectoral Asset Management's portfolio value fell 9% quarter-over-quarter to $2.18B.

Based on Sectoral Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.